After at Profiles Theatre
We can't wait for opening night TONIGHT, and we'll have a full review up shortly.
When a wrongfully imprisoned man is exonerated by DNA evidence after seventeen years in prison, he is forced to re-assimilate into a cold, foreign world of toothbrush shopping, doggy day care, and a friendship with an anxious young woman with secrets of her own. After is a compassionate portrait of a man struggling with the challenges of socializing and the anger he still feels for having his youth unjustly destroyed.
Schedule: Thurs., Fri.: 8:00 p.m.
Saturday: 5:00 p.m. and 8:00p.m. (no 5pm show September 1 and 8)
Sunday: 7:00 p.m.
Location: Profiles Theatre, The Alley Stage, 4147 N. Broadway
Parking is available for $10 - $12 at 4100 N. Clarendon
(One block east of the theatre at the corner of Clarendon and Belle Plaine)
Ticket prices:
Thursdays are $35, Fridays, Saturdays and Sundays are $40; Students and Senior Citizens receive a $5 discount on all performances; Group rates are available.
Box Office: Buy online at www.profilestheatre.org
or call (773) 549-1815
**Check out our prior coverage and full show details here.**
Writers’ Theatre presents
Hamlet
written by William Shakespeare
directed by Artistic Director Michael Halberstam
featuring Scott Parkinson in the title role
Writers’ Theatre, under the direction of Artistic Director Michael Halberstam and Executive Director Kathryn M. Lipuma, opens its 21st season with Hamlet, written by William Shakespeare and directed by Artistic Director Michael Halberstam. The production runs September 4, 2012 – November 11, 2012 at Writers’ Theatre, 325 Tudor Court in Glencoe.
The king is dead—murdered by his own brother, who has claimed the throne and the widowed queen. And the world goes on…but the Prince cannot. Shakespeare’s greatest tragedy is equal parts ghost story, political intrigue, doomed romance and murder mystery, driven by one of literature’s most intriguing, enigmatic and controversial characters.
**Check out our prior coverage and full show details here.**
No comments:
Post a Comment